Table 1.
Mitochondrial DNA depletion syndromes | Period of onset | Clinical features | Genes (aliases) | Chromosomal LOCI | Numbers of mutations | References* |
---|---|---|---|---|---|---|
Hepatocerebral mtDNA depletion syndrome |
Neonatal, early childhood |
Hepatic dysfunction; psychomotor delay; hypotonia; lactic acidosis; nystagmus; neurological dysfunction |
POLG (Polg1/PolgA) |
15q25 |
8 |
[10] |
C10orf2 (Twinkle/PEO1) |
10q24 |
3 |
[11] |
|||
DGUOK (dGK) |
2p13 |
51 |
[12] |
|||
MPV17 (SYM1) |
2p23.3 |
28 |
[13] |
|||
|
|
|
TK2 |
16q22-q23.1 |
1 |
[14] |
Alpers-Huttenlocher syndrome |
Early childhood |
Hepatic dysfunction; epilepsia partialis continua; neurological dysfunction |
POLG (Polg1/PolgA) |
15q25 |
54 |
[15] |
Myopathic mtDNA depletion syndrome |
Infancy, early childhood |
Hypotonia; muscle weakness; dysarthria and dysphagia; failure to thrive |
POLG (Polg1/PolgA) |
15q25 |
1 |
[5] |
TK2 |
16q22-q23.1 |
34 |
[16] |
|||
RRM2B (p53R2) |
8q23.1 |
3 |
[5] |
|||
|
|
|
DGUOK (dGK) |
2p13 |
1 |
[17] |
Encephalomyopathic mtDNA depletion syndrome |
Infancy |
Hypotonia; muscle weakness; psychomotor delay; sensorineural hearing impairment; lactic acidosis; neurological dysfunction |
RRM2B (p53R2) |
8q23.1 |
14 |
[18] |
TK2 |
16q22-q23.1 |
1 |
[19] |
|||
SUCLA2 |
13q12.2 |
9 |
[20] |
|||
|
|
|
SUCLG1 |
2p11.3 |
13 |
[21] |
Mitochondrial neurogastrointestinal encephalomyopathy |
Late childhood, adolescence |
Gastrointestinal dysmotility; weight loss; peripheral neuropathy;ptosis; neurological dysfunction |
TYMP (ECGF1) |
22q13 |
81 |
[22] |
RRM2B (p53R2) |
8q23.1 |
2 |
[23] |
|||
POLG (Polg1/PolgA) | 15q25 | 1 | [24] |
MDS are inherited in an autosomal recessive pattern; mutations in POLG gene outside MDS may be associated with autosomal recessive/dominant pattern of inheritance. *References of the first mutations published associated with the phenotype.